Here’s what you should know:
1. The companies expect the test will be available in 2020.
2. The tests detect polyp and carcinogenesis warning signs in the colon.
3. Prescient Medicine CEO and Founder Keri Donaldson said, “These simple yet incredibly powerful tools will dramatically change the equation when it comes to earlier identification of precancerous conditions, leading to early treatment decisions, reduced costs and better outcomes. Metabiomics is an extraordinary partner in our mission to prevent disease and provide the very best care at the lowest possible cost to the healthcare system.”
More articles on gastroenterology:
Envision loses another contract over out-of-network billing & more — 11 ASC company key notes
Total charges for top 10 procedures performed at ASCs in the Northeast
10 strategies to streamline ASC supply chain management
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
